HIGHLIGHTS
- who: Anthony Goncalves from the (UNIVERSITY) have published the paper: The CINSARC signature predicts the clinical outcome in patients with Luminal B breast cancer, in the Journal: (JOURNAL)
- what: The authors built a prognostic clinicogenomic model based on these three variables in a randomly defined learning set of 247 samples and tested its prognostic value in the validation set of 247 remaining samples: as shown in Fig 3, the model was robust and identified an even lower risk subgroup with 5-year DFS of 93% (95%CI ).
- how: The study is based upon . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.